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Abstract
There is a body of literature that describes the geometry and the physics of filopodia using either stochastic models or
partial differential equations and elasticity and coarse-grained theory. Comparatively, there is a paucity of models focusing
on the regulation of the network of proteins that control the formation of different actin structures. Using a combination of
in-vivo and in-vitro experiments together with a system of ordinary differential equations, we focused on a small number of
well-characterized, interacting molecules involved in actin-dependent filopodia formation: the actin remodeler Eps8, whose
capping and bundling activities are a function of its ligands, Abi-1 and IRSp53, respectively; VASP and Capping Protein (CP),
which exert antagonistic functions in controlling filament elongation. The model emphasizes the essential role of complexes
that contain the membrane deforming protein IRSp53, in the process of filopodia initiation. This model accurately
accounted for all observations, including a seemingly paradoxical result whereby genetic removal of Eps8 reduced filopodia
in HeLa, but increased them in hippocampal neurons, and generated quantitative predictions, which were experimentally
verified. The model further permitted us to explain how filopodia are generated in different cellular contexts, depending on
the dynamic interaction established by Eps8, IRSp53 and VASP with actin filaments, thus revealing an unexpected plasticity
of the signaling network that governs the multifunctional activities of its components in the formation of filopodia.
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Introduction
Filopodia, actin-rich, finger-like structures that protrude from the
cell membrane of a variety of cell types, play important roles in cell
migration, neurite outgrowth and wound healing [1]. Filopodia are
characterized by a small number of long and parallel actin filaments
that deform the cell membrane, giving rise to protrusions. In order
for filaments to grow to the characteristic length observed in
filopodia, capping proteins, specialized molecules that inhibit actin
polymerization, need to be locally inhibited or sequestered and
nucleation of new filaments needs to be favored. Furthermore,
individual actin filaments are not sufficiently stiff to deform the cell
membrane [2]. Proteins, such as VASP-family proteins are thought
to be required to promote the initial transient association of actin
filaments as they directly [3] or indirectly antagonize capping
proteins [4], capture barbed ends [5] and cross-link actin filament
[4,5]. Furthermore, they can act as processive filament elongators
especially upon high-density clustering, at least in vitro [4,6,7].
Actin filaments are then further stabilized by other crosslinkers, such
as fascin, thus permitting the formation of bundles of sufficient
stiffness to overcome buckling and membrane resilience [8]. Thus,
in a simplified view, capping proteins can be seen as inhibitors, while
bundling proteins are among the necessary components of filopodia
formation. Consistently with this picture, removal of Capping
Protein (CP) causes an increase in the number of filopodia [9]. Vice
versa, cells devoid of the actin crosslinker fascin display a reduced
amount of filopodia [8].
This simple rule does not seem to apply easily to the actin
remodeler Eps8, which plays complex roles in filopodia formation
reflecting its diverse biochemical functions. Eps8 can efficiently
cap barbed ends when bound to Abi-1 [10], while it crosslinks
actin filaments, particularly when it associates with IRSp53
(Insulin Receptor Tyrosine Kinase Substrate of 53 KD)
[11,12,13,14], a potent inducer of filopodia via its ability to bind
actin filaments and deform the plasma membrane (PM) through its
IMD domain [15]. Consistent with its dual function, the role of
Eps8 in filopodia formation is cell context-dependent. In HeLa
and other epithelial cell lines, the ectopic expression of Eps8 in the
presence of IRSp53 promotes the formation of filopodia, while its
removal reduces them [12]. The opposite behavior is observed in
primary hippocampal neurons, where genetic removal of Eps8
increases the formation of axonal filopodia [16].
PLoS Computational Biology | www.ploscompbiol.org 1 July 2011 | Volume 7 | Issue 7 | e1002088
In order to rationalize the information described so far, we
propose that the process of filopodia formation proceeds in a step-
wise fashion. During an initial phase, multiple and simultaneous
binding reactions (primarily involving cappers, bundlers and
filamentous actin) lead to the formation of pre-existing filaments
into bundles. In a second phase, elongation of these bundled
filaments is required to support the extension of filopodia.
Hitherto, efforts in modeling filopodia formation have focused
on the structure and physical properties of filopodia [17,18,19,20]
as well as into the role of specific proteins in modulating the
characteristic of individual filopodia [21]. More recently, some
models have started to couple a detailed biophysical description of
filopodia dynamics with some of the molecules involved with
capping and bundling [22,23]. However, it is extremely challeng-
ing to treat with the same model filopodia formation in terms of
theory of elasticity or stochastic simulations while keeping track of
the full behavior of the complex protein-protein interactions
underlying the formation of bundled filaments. Particularly, the
effect of modifications (e.g. gene deletions or over-expression)
affecting the network has never been approached so far with
computational methods.
Here, we combined computational models, in-vitro and in-vivo
experiments and describe in mathematical terms the behavior of
the protein-protein interaction network underlying the formation
of bundled filaments using a minimal but biologically relevant
module, centered on the IRSp53/Eps8/VASP pathway, with the
aim of defining general principles governing the formation of
filopodia in different cellular contexts.
Results
The IRSp53/Eps8/VASP molecular network
In this section, we first introduce the topology of the network
underlying filament bundling (Fig. 1). Together with the network
that we intend to model, we also enlist the assumptions adopted to
translate the network in mathematical formalism. We then discuss
the determination of the parameters used for the simulations.
Polymerization of actin
In-vivo, capping proteins block most of the barbed ends
preventing uncontrolled filament elongation [24]. Additionally,
most of the G-actin available for polymerization is bound to
profilin, a monomeric actin binding protein that promotes the
exchange of ADP to ATP and decreases the affinity of monomeric
actin for filament pointed ends and spontaneous filament
nucleation [25]. Accordingly, in our model, polymerization occurs
at barbed ends only (equations in Table 1 in Text S1). Under these
conditions, the rate of polymerization is proportional to the total
G-actin concentration and to the number of free barbed ends.
While local G-actin concentration can vary due to local
polymerization and depolymerization fluxes [26,27], the total
concentration of G-actin in cells is maintained buffered through
mechanisms involving ATP turnover and actin sequestering
proteins [28], and thus we treat it as a fixed parameter in our
model. This choice is particularly suited to our analysis, which
aims to reproduce steady state behaviors and not transient
dynamics. We used a concentration of 10 mM of G-actin available
for polymerization in cells as estimated in [27,29].
As for depolymerization, we introduce dissociation of mono-
mers from barbed ends. Since for our purposes a simplified
description of actin polymerization suffices, we ignore pointed
ends dynamics, while, following a formalism presented in [30] we
include a turnover for actin proportional to the total amount of F-
actin. Notably, even if we explicitly account for pointed ends
polymerization and depolymerization together with a variable
amount of G-actin, the results of the model are qualitatively
similar (unpublished results). Finally, since the model is based on
ordinary differential equations, we do not explicitly take into
account individual filaments with variable amounts of actin, but
identify a bulk of polymerized actin, F-actin (Fa).
Capping
In the cell types we examine, two cappers, CP and the
Eps8:Abi-1 complex, play important roles in filopodia formation.
We thus explicitly introduce these two molecular species and their
interaction with barbed ends in the network (Fig. 1).
Cells tightly control polymerization by maintaining most barbed
ends capped, since uncapped filaments in cellular extracts would
elongate due to G-actin concentrations higher than the critical
concentration for barbed ends [31]. Thus, in our model we assume
that, at the steady state, the nucleation and depolymerization of
filaments results in a fixed total number of barbed ends and that
the concentration of capping proteins (CP and the complex
Eps8:Abi1) is sufficiently high to cap most of them.
The behavior of the system ‘‘out of steady state’’ (e.g., bursts of
polymerization giving rise to the growth of individual filopodia) is
not analyzed experimentally and thus, as anticipated, will not be
reproduced by the simulations. We use the model only to
reproduce changes in the steady state behavior of the network in
various genetics backgrounds where components of the network
are either deleted or over-expressed. Finally, we purposely avoided
including the anti-capping activity of VASP family members as its
role in filopodia formation is still unclear [32], and little is known
as to whether this activity is regulated upon binding of these
proteins to IRSp53.
Bundling complexes
Bundling activity of EPS8:IRSp53. The Eps8:IRSp53
complex was previously characterized as an actin bundler
capable of inducing filopodia formation [12]. Individually, Eps8
and IRSp53 are both weak bundlers, but they can interact forming
an Eps8:IRSp53 complex that displays increased actin bundling
activity in the bulk solution (Fig. 2A and Fig. S1A–B). In the
model, the complex Eps8:IRSp53 favors bundling by binding to
the side of actin filaments, thus generating a ‘‘filopodia initiation
complex’’ (i.e., Eps8:IRSp53:Fa) (see later for a thorough
Author Summary
Cells move and interact with the environment by forming
migratory structures composed of self organized polymers
of actin. These protrusions can be flat and short surfaces,
the lamellipodia, or adopt an elongated, finger-like shape
called filopodia. In this article, we analyze the ‘computa-
tion’ performed by cells when they opt to form filopodia.
We focus our attention on some initiators of filopodia that
play an essential role due to their interaction with the cell
membrane. We analyze the formation of these filopodia
initiators in different genotypes, thus providing a way to
rationalize the behaviors of different cells in terms of
tendency to form filopodia. Our results, based on the
combination of experimental and computational ap-
proaches, suggest that cells have developed molecular
networks that are extremely flexible in their capability to
follow the path leading to filopodia formation. In this
sense the role of an element of the network, Eps8, is
paradigmatic, as this protein can both induce or inhibit the
formation of filopodia depending on the cellular context.
The Eps8/IRSp53/VASP Network
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explanation). This reaction, as all others, takes place following
simple mass action kinetics.
Thus, Eps8 can form complexes with Abi-1, capable of capping
activity, and with IRSp53, capable of bundling. While Abi-1 and
IRSp53 bind to Eps8 in-vitro on different surfaces [12], in-vivo, Eps8
is present in two distinct sub-populations: together with Abi-1 on
barbed ends along the cell membrane and together with IRSp53
along bundled actin filaments such as microspikes and filopodia,
suggesting the presence of two distinct complexes. Consistently,
co-immunoprecipitation experiments of endogenous proteins in
various cell lines showed no evidence of the existence of the triple
complex [16]. Thus, in our model Eps8 can bind IRSp53 or Abi-1;
the two binding reactions being in competition with each other.
Bundling activity of VASP. The ability of VASP to favor
filopodia formation is well established, but the biochemical
mechanisms through which this function is exerted are still
controversial due to a variety of activities that this protein possesses
[4,5,7,32,33,34,35]. While VASP displays actin bundling ability in
in-vitro bulk experiments (Fig. 2A and S1A–B), this does not reflect
in the capability to induce filopodia formation when expressed
alone in-vivo (Fig. S1C). This result prompted us to seek possible
factors that cooperate with or directly enhance VASP crosslinking
activity.
One candidate protein that may fulfill this latter role is IRSp53.
Binding of IRSp53 to Mena, a member of the VASP-family
proteins, has been previously reported [36]. Moreover, the two
proteins were shown to act in synergy in promoting filopodia
formation supporting their functional interaction [36]. In keeping
with this latter notion, functional interference with VASP-family
proteins by sequestering away from the plasma membrane in cells
over-expressing IRSp53 decreases the number of filopodia, hinting
that VASP might act downstream of IRSp53 [12]. Intrigued by
this possibility, we tested for synergies between VASP and IRSp53
in bundling actin filaments. In the presence of excess IRSp53, the
ability of VASP to bundle filaments in in-vitro bulk experiments was
increased 100 fold (Fig. 2A and S1A–B). This was paralleled by the
ability of IRSp53 to localize VASP at sites of membrane curvature
and to cause formation of filopodia in-vivo (Fig. S1C), similar to the
Eps8:IRSp53 complex. To further characterize the interaction
between VASP and IRSp53, we employed purified proteins and
Figure 1. Eps8 and IRSp53 effector network. Network showing the main interactors of Eps8 and IRSp53 involved in the regulation of filopodia
formation. Black filled dots indicate substrates of a reversible binding reaction, whose product is pointed by an arrow. Turnover of filamentous actin
(reaction (9)) is the only irreversible reaction depicted in the diagram. In the network, we identify two different modules, a capping module, which
includes the binding reactions between cappers and barbed ends, and a bundling module, which includes the binding reactions between bundlers
and filamentous actin. CP represents Capping Protein, cyan circles are polymerized monomers of actin; the red circle marked Ga is G-actin. B and P
mark the barbed and pointed ends, respectively, of a filament of actin. Reaction numbers and the shortened names in parentheses under the icons
allow an easy interpreation of the equations of the model (Table 1 in Text S1).
doi:10.1371/journal.pcbi.1002088.g001
The Eps8/IRSp53/VASP Network
PLoS Computational Biology | www.ploscompbiol.org 3 July 2011 | Volume 7 | Issue 7 | e1002088
in-vitro assays. VASP binds to IRSp53 with significant affinity in
the nM range (Fig. 2B), mainly through an interaction between the
proline rich region of VASP and the SH3 domain of IRSp53. This
latter domain also mediates the binding to Eps8, suggesting that
VASP and Eps8 may directly compete for binding to IRSp53’s
SH3 domain. Notably, the affinity between Eps8 and IRSp53 is
very similar to the affinity between VASP and IRSp53
(dissociation constants kD_EI = 10 nM and kD_VI = 12.5 nM,
respectively) [12].
We thus set out to test directly whether Eps8 and VASP can
compete for IRSp53 binding both in-vitro and in-vivo. Addition of
the proline-rich region of Eps8 (PPP), the minimal region of
interaction with the SH3 domain of IRSp53, to a fixed amount of
VASP and IRSp53 decreased the amount of VASP:IRSp53
complex formed in a concentration-dependent manner (Fig. 2C).
Additionally, in-vivo, IRSp53, but not Eps8, could be recovered on
anti-VASP immunoprecipitates of HeLa cell extracts suggesting
the existence of two distinct, mutually exclusive complexes
(Fig. 2D).
Based on this evidence, we introduced in the model a second
interactor of IRSp53, VASP, that competes with and is able to
cause filopodia formation independently of Eps8 (Fig. 1). We
estimated the affinity of the Eps8:IRSp53 complex for the side of
the actin filament from low-speed centrifugation assays using the
bundling domain of Eps8, and from similar experiments
measuring the affinity of the IMD domain of IRSp53 [10,37].
The affinity of VASP:IRSp53 for the actin filament was assumed
to be 100 fold higher based on its ability to induce actin
crosslinking at lower concentrations (Fig. 2A and Fig. S1) (notably,
an increase of 1000 times, closer to the experimental value, would
not change the result). Although these affinities are deduced from
bulk experiments, we assume that they remain roughly unchanged
Figure 2. VASP synergizes with IRSp53 in bundling actin filaments and competes with Eps8 for IRSp53 binding. a. Isolated VASP and
Eps8 bundle actin filaments with low efficiency, which is enhanced by their association with IRSp53. The bundling efficiency was determined by
measuring the number of bundles/field obtained in fluorescence microscopy-based F-actin-bundling assays as described and shown in Fig. S1A–B. At
least 10 fields per experiment performed in triplicates were scored. Data are the mean6 s.e.d. b. Measurement of IRSp53 and VASP interaction. Equal
amounts (10 pmoles) of His-IRSp53, GST-IRSp53-SH3 or BSA were spotted onto nitrocellulose and incubated with increasing concentrations of
purified VASP. The nitrocellulose filter was then subjected to WB analysis using anti-VASP antibody (Ab). The fraction of VASP bound was plotted
against the concentrations of total VASP. An apparent dissociation constant was calculated using standard procedure as described in [12]. c. The
proline rich region of Eps8 (PPP) competes with VASP for binding to IRSp53. Equal amounts (10 pmoles) of His-IRSp53 spotted onto nitrocellulose
and incubated with purified 100 nM VASP or BSA as control, in the absence or the presence of increasing amounts of the proline-rich region of Eps8
(GST-PPP) or GST. The filters were immunoblotted with the indicated abs. d. VASP forms a complex with IRSp53 in-vivo. Lysates (1 mg) of HeLa cells
were immunoprecipitated with anti-VASP or with control abs. Lysates (20 mg) and immunoprecipitates (IP) were immunoblotted with the indicated
abs. The bottom panel is a longer exposure to visualize endogenous levels of VASP.
doi:10.1371/journal.pcbi.1002088.g002
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even when the ‘‘filopodia initiation complexes’’ are formed at the
PM. Likewise Eps8:IRSp53, we introduce binding of VAS-
P:IRSp53 to filamentous actin following simple mass action
kinetics, to form a ‘‘filopodia initiation complex’’, VAS-
P:IRSp53:Fa.
Filopodia formation in the model
The formation of filopodia requires a number of other
components in addition to those included in the model, most
importantly fascin. However, we argue that the filopodia initiation
complexes Eps8:IRSp53:Fa and VASP:IRSp53:Fa play a critical
role likely in the initial phase of filopodia formation when filaments
must be congregated in close proximity to the plasma membrane.
These two filopodia initiation complexes share the critical and
unique property to be anchored, primarily through IRSp53 and its
membrane curvature sensing IMD module, to the plasma
membrane, and thus show a high affinity for convex membrane
curvature [1,15]. Under these conditions, we hypothesize that the
two complexes are ideally located to facilitate the ‘‘convergence’’
of actin filaments by promoting their bundling at the PM-oriented
barbed ends. Notably and consistently with our hypothesis, actin
filaments bundles have been recently proposed to be necessary for
efficient protrusion by filling the space and providing mechanical
support to the initial membrane deformation induced by IRSp53
that precedes the extension of filopodia [38]. Based on these
considerations, we propose the ‘‘initiation of bundling’’ at the PM
as the critical step in filopodia initiation, which is primarily due to
the activity of Eps8:IRSp53 and VASP:IRSp53 and their ability to
form initiation complexes with F-actin, upon which we focus our
attention. Further supporting the important role of IRSp53-
complexes in filopodia formation, theoretical studies show that
membrane-bound protein complexes that have convex curvature
and enhance actin polymerization, are able to initiate membrane
protrusions [39]. As such, in our model we limit our analysis to the
formation of Eps8:IRSp53:Fa and VASP:IRSp53:Fa, from now on
abbreviated as FIC for ‘‘filopodia initiation complexes’’.
In a given cell population, the concentrations of the two FIC are
expected to be distributed according to a normal (Gaussian)
distribution centered around a mean value. Notably, only some of
the cells of a population will develop filopodia, whereas others will
not, accounting for the observation that filopodia formation shows
a threshold behavior [40]. Recent models [39,41] allow us to
rationalize the threshold behavior based on a positive feedback
loop triggered by FIC localized at the plasma membrane. When
the mean concentration of FIC increases over a threshold value,
they induce the spontaneous initiation of membrane protrusions
through the following positive feedback mechanism: a local higher
concentration of initiation complexes induces a higher local actin
polymerization and protrusive force, which creates a local
membrane protrusion and drives the accumulation of even more
complexes since they are attracted to the convex curvature at the
protrusion tip. Filament elongation and anti-capping activities
might also involved in this second step following the formation of
FIC. Importantly, as explained above, both the FIC considered
here belong to the class potentially involved in the loop, i.e. they
have both convex curvature (IRSp53) and promote actin
polymerization against the plasma membrane, by increasing
filament stiffness through their bundling activity. Accordingly,
we hypothesize, following this model, that only the fraction of cells
that reaches the threshold value of initiators concentration can
activate the feedback loop and develop filopodia, as shown for a
generic system in Fig. 3A.
We can compute the fraction of cells that crosses the threshold
for filopodia formation as a function of the mean value of FIC in
the cell population, assuming that this latter has a normal
distribution of FIC. The resulting fraction of cells developing
filopodia has an Error-function (Erf) dependence on the average
concentration; it increases linearly as the average concentration
Figure 3. Average concentrations of filopodia initiator correlates with the probability of forming filopodia. a. Distributions of the
concentration of filopodia initiators (FI) in cell populations with different mean values (m) and identical standard deviations, computed as
1ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2ps2
p e{ FI{mð Þ
2
2s2 . The concentration of FI required for initiating the positive feedback loop (FIcrit) is shown as a dotted line. As m increases (different
colored curves) the fraction of cells with FI.FIcrit increases. b. Fraction of cells in a population with FI.FIcrit as a function of the average FI
concentration m. Different color squares represent the fraction of cells for the different Gaussians shown in A. To calculate the amount of cells with
FI.FIcrit, we simply integrate the Gaussian from FIcrit to infinite,
ð?
FPcrit
1ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2ps2
p e{ FI{mð Þ
2
2s2
.
doi:10.1371/journal.pcbi.1002088.g003
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increases around the threshold value, and saturates far above or
below (Fig. 3B). This result suggests that there is a regime where
the average concentration of FIC is linearly proportional to the
fraction of cells that develop filopodia. Following this line of
reasoning, we focused on a deterministic model that computes the
average amount of initiation complexes present in the different
genotypes.
To compare filopodia formation among different cell types,
rather than measuring the percentage of cells that develop
filopodia in a given genotype we normalized their value relative
to the wild type (WT). The resulting ‘relative filopodia index’
(RFI), is the fraction of cells forming filopodia at steady state in a
population of cells functionally interfered for the gene of interest
(e.g., X), divided by the fraction of filopodia forming cells
transfected with scrambled RNAi oligo:
RFI~
Number of Cells Xð Þ forming Filopodia
Total Number of Cells Xð Þ
Number of Cells WT-scrð Þ forming Filopodia
Total Number of Cells WT-scrð Þ
Accordingly, in the model we did not simply calculate the
concentrations of filopodia initiation complexes, but a ‘filopodia
initiation index’ (FII) defined as the concentrations of filopodia
initiation complexes Eps8:IRSp53:Fa and VASP:IRSp53:Fa,
normalized by their concentration in wild type cells:
FII~
Eps8 : IRSp53 : Fa½ Xz VASP : IRSp53 : Fa½ X
Eps8 : IRSp53 : Fa½ WTz VASP : IRSp53 : Fa½ WT
Throughout the manuscript, we will compare these two quantities
to test the capability of the model to reproduce experimental data
and predict new results.
Cellular concentration of proteins and rate constants
To perform numerical simulations of filopodia formation in
HeLa cells and neurons, we need to know the concentrations of
the different species. Previous measurements showed that Eps8
and Abi-1 are present in similar concentrations in the two cell
types, while Abi-2 is less concentrated in HeLa cells [16]. We then
determined IRSp53 concentration through quantitative immuno-
blotting, and found that it is expressed at similar concentrations in
both cell lines (Fig. S2A). As for VASP, we measured its
concentration in HeLa cells to be in the submicromolar range
(Fig. S2B). We could not directly measure the concentration of
VASP in neurons due to the lack of antibodies equally effective
against the mouse and human protein. However, reports in the
literature show that Mena and EVL, the other two proteins in the
VASP-family, are specifically expressed in brain at micromolar
concentrations and that the three members of the family show
high and overlapping expression levels in developing brain
[42,43,44,45]. Accordingly, we used a concentration of VASP-
family protein higher in neurons than in HeLa cells. As for kinetic
parameters for the various binding reactions, they were derived
from the literature or measured directly (Fig. 2, Fig. S2 and Table
2 in Text S1).
Finally, when a protein was over-expressed, we assumed its
concentration was increased 10 fold over its wild type values. For
knockdown experiments via RNAi, we assumed that the protein
concentration was reduced to 1/10th.
Simulations and experimental results
After setting the topology of the network, having established the
values of key parameters and identified an output that can be
compared with the formation of filopodia, we utilized our model to
explain the fundamental observation that removing Eps8 decreas-
es filopodia formation in HeLa cells, but causes an increase in
filopodia formation in neurons.
Phenotypes of HeLa cells
In HeLa cells, genetic experiments measuring filopodia
formation were done under conditions of IRSp53 over-expression
(a condition that we define as WT), which in the model translates
with concentrations of IRSp53 10 times larger than concentrations
of Eps8 and VASP. The RFI was then measured in wild type and
in cells in which we individually knocked down Eps8 or Abi-1 or
functional interfered with VASP proteins or both with Eps8 and
VASP simultaneously [12]. We then compared the fold increase in
RFI measured in these cells with the fold increase of the FII in the
model and found a good agreement (Fig. 4A). According to our
model, in HeLa cells over-expressing IRSp53 the majority of Eps8
is bound to IRSp53 and filamentous actin, and very little is
capping barbed ends (compare the red bar in the first two panels of
Fig. 4B). Similarly, in HeLa cells no Abi-1 or Abi-2 co-
immunoprecipitated with Eps8 [16]. We used the model to have
an inside view of what happens to filopodia initiators and other
protein complexes in the various genetic mutants after RNAi
interference of the individual proteins of the network.
Simulations show that Eps8 knock down caused a reduction in
the amount of Eps8:IRSp53:Fa (Fig. 4B, compare red and orange
bars in the second panel) leading to a decrease in the total amount
of filopodia initiation complexes (Fig. 4A). Although VASP and
Eps8 compete for the binding with IRSp53, in our model removal
of Eps8 did not significantly increase the amount of VASP-family
proteins bound to it (see IRSp53:VASP:Fa, where ‘‘VASP’’
includes VASP-family proteins, in Fig. 4B, red and orange bars
in the third panel). We confirmed this prediction by immuno-
precipitating VASP in WT HeLa and HeLa cells knocked down
for Eps8 (Fig. 4C) and verifying that the amount of IRSp53 bound
to VASP remained constant. Simulations suggest that VASP’s role
is very similar to that of Eps8: indeed, functional removal of VASP
caused a decrease in VASP:IRSp53:Fa (Fig. 4B, red and green
bars in the third panel) and filopodia initiators in general (Fig. 4A).
As VASP and Eps8 are redundant activators of IRSp53, the
simultaneous down-regulation of both causes an increased
reduction in filopodia formation, as predicted by the model
(Fig. 4A).
As for the capping activity of Eps8 in this cell line, our
simulations suggest that it does not play an important role. The
complex Eps8:Abi-1 is very scarce and the removal of Abi-1 did
not affect the amount of filopodia initiators (Fig. 4A and red and
blue bars in the second and third panels in Fig. 4B).
Thus, our model supports the idea that the primary capping
protein in HeLa cells is CP, and that Eps8 acts almost exclusively
as a bundling protein downstream of IRSp53.
Phenotypes of hippocampal-neurons
In hippocampal neurons, removal of the different activators of
IRSp53 leads to drastically different effects [16]. Functional
interference with all VASP-family proteins inhibits filopodia
formation similarly to what observed in HeLa cells after
simultaneous ablation of Eps8 and VASP [12,46] (Fig. 5A, red
and purple bars). However, in neurons, but not in HeLa cells, the
removal of Eps8 alone causes a large increase in the formation of
filopodia along the neuronal shaft (Fig. 5A, red and yellow bars)
[16,46]. We used our model to understand the reasons behind this
apparently paradoxical behavior.
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The network described in Fig. 1 applies to both HeLa and
hippocampal neurons; therefore we used the same set of equations
and parameters for both cell types, with the noticeable exception
of the concentrations of some proteins, Table 2 in Text S1. In
hippocampal neurons, in fact, Abi-2 is expressed at much higher
levels than in HeLa [16]. Similarly, all members of the VASP-
family proteins are specifically and abundantly expressed in
neurons and are presumably in excess with respect to IRSp53 as
explained above. Moreover, at variance with respect to the
experiments performed in HeLa, the analysis of axonal filopodia
was conducted under conditions in which IRSp53 was not
ectopically elevated. Accordingly, for neurons in the model we
used a value of IRSp53 10 times smaller than in HeLa cells, and
Abi-1 (which accounts for the presence of Abi-2) and VASP (which
accounts for all VASP family members) were increased by a factor
5 (see Table 3 in Text S1).
The fold change in FIC derived from the simulations of our
model were consistent with the experimental results obtained in
WT, and Eps8 null hippocampal neurons either in the absence or
the presence of a VASP dominant negative, which impairs the
functional activity of all VASP family members [16] (Fig. 5A). A
deeper analysis of the model’s behavior allowed us to rationalize
the phenotypes in molecular terms. Simulations of WT hippo-
campal neurons under condition of limiting IRSp53 (i.e.
endogenous levels of the protein) suggest that a significantly
higher fraction of Eps8 is bound to Abi-1 or Abi-2 compared to
HeLa cells, to form the capping-active Eps8:Abi-1/2 complexes
(compare red bar of the first panel in Fig. 4B with red bar of the
first panel in Fig. 5B). Consistent with this notion, we previously
reported that Eps8 binds a significant amount of Abi-1 and Abi-2
in neurons but not in HeLa cells [16]. Since a minimal fraction of
Eps8:IRSp53 is bound to filamentous actin, the major filopodia
initiator in neurons consists of VASP-family proteins bound to
IRSp53 and Fa (compare red bars of panels two and three in
Fig. 5B). Having defined the WT condition in hippocampal
neurons, we set to analyze the change in steady state caused by the
removal of Eps8.
In our simulations, removal of Eps8 increases the total amount
of uncapped ends, causing an increase in the amount of
filamentous actin (not shown). Moreover, we also observe an
increase in the formation of the VASP:IRSp53 complex, due to
the competition between VASP-family proteins and Eps8 for the
scarce amount of IRSp53 available. As VASP:IRSp53 binds to
filamentous actin with higher affinity than Eps8:IRSp53, the
model predicts an increase in initiator complexes (compare red
and orange bars in the third panel of Fig. 5B), which gives rise to a
fold change in FIC for Eps8 knock out similar to what
experimentally observed (Fig. 5A). We confirmed this result by
immunoprecipitating IRSp53 in WT and Eps8 knock out neurons
and observed that a higher amount of VASP was recovered in the
knock out neurons (Fig. 5C). In our model, the increase in
filopodia initiators due to Eps8 removal is reversed by the
simultaneous functional interference with VASP-family proteins
(Fig. 5A and orange and purple bars in panel four of Fig. 5B)
consistent with what was experimentally measured [16].
We conclude that the role of Eps8 in neurons is more complex
than in HeLa cells: in the former cells, it contributes to capping
and competes with VASP-family proteins for the formation of
filopodia initiators.
Model’s predictions
To further validate the model, we used it to make quantitative
predictions about novel phenotypes. CP removal has been
reported to cause an increase in filopodia formation in multiple
cell-lines with high quantities of VASP-family proteins [9], but not
in cell lines genetically devoid of VASP. The lack of filopodia
formation in these latter cells was interpreted as an indication that
VASP-family proteins are required for filopodia formation
following the removal of capping proteins. This interpretation is
in agreement with our model, according to which VASP induces
filopodia formation via the initiator VASP:IRSp53:Fa. Our
experiments also support this view, as we showed that VASP in
complex with IRSp53 can induce filopodia formation in-vivo and
formation of actin bundles in-vitro. However, in our model, VASP
is not the only source of filopodia initiators. Eps8:IRSp53:Fa is also
capable of inducing filopodia formation independently of VASP.
Thus, we reasoned that in a setting where VASP cannot contribute
to filopodia formation, CP removal should still lead to an increase
in the fraction of cells producing filopodia via the parallel pathway
provided by Eps8:IRSp53.
To test this prediction we analyzed the change in filopodia
formation induced by CP removal in fibroblasts genetically devoid
of VASP and MENA and expressing undetectable levels of EVL
(MVD7 cells) [47].We first measured the concentrations of IRSp53,
Eps8 and Abi1, as compared to the concentrations measured in
HeLa, and we found that MVD7 cells have less Abi1, more Eps8
and roughly the same concentration of IRSp53 (Fig. S2C and Table
2 in Text S1). Next, as these cells do not normally produce filopodia,
we over-expressed IRSp53 (a condition called WT, in analogy to
what done with HeLa cells) to induce these structures in a sizeable
fraction of cells in the population, and we calculated the IRSp53-
dependent relative filopodia index of CP knocked down cells with
respect to scrambled siRNA-transfected cells (Fig. 6A–B). Using the
calculated concentrations of the relevant proteins of MVD7 cells,
while keeping the same binding parameters employed in HeLa
(Table 2 in Text S1), the model predicted an increase of FII due to
CP removal (Fig. 6C) as compared to the WT. The prediction was
verified in-vivo by down-regulating CP via RNAi. Of note, the
agreement between FII and RFI is quantitative.
According to the model, the increase in uncapped filaments
leads to an increase in filamentous actin, and as a consequence to
an increase in IRSp53:Eps8:Fa filopodia initiation complex
(compare red and blue bars in Fig. 6D second panel). The
increase in uncapped filaments also causes the amounts of
Eps8:Abi-1 capping filaments to increase (compare red and blue
bars in Fig. 6D first panel), but this was insufficient to compensate
for the loss of CP due to the low amounts of Abi-1 present.
Our model predicts that a similar effect should also be observed
in HeLa cells over-expressing IRSp53 (Fig. S3), where VASP is
present but no longer capable of forming new initiation complexes
Figure 4. Eps8 plays a major role as a bundler, and not as a capper, in HeLa cells. a. Change in RFI and FII in the various genetic
backgrounds. Empty rectangles represent experimental results (see Table 3 in Text S1), filled rectangles simulations of equations in Table 1 in Text S1
and parameters in Table 2 and Table 3 in Text S1. b. Complexes formed in HeLa cells by Abi1, Eps8, IRSp53, and VASP in different genetic
backgrounds, plotted as percentage of total protein concentration in the wild type. Simulations performed as in a. c. Removal of Eps8 from HeLa cells
does not significantly increase the amount of VASP bound to IRSp53. Lysates (1 mg) of HeLa control cells treated with a scrambled oligo [WT (scr)] or
interfered for Eps8 (Eps8 K.d.) were immunoprecipitated with VASP or control abs. Lysates (40 mg) and immunoprecipitates (IPs) were immunoblotted
with the indicated abs. IgG are also indicated.
doi:10.1371/journal.pcbi.1002088.g004
The Eps8/IRSp53/VASP Network
PLoS Computational Biology | www.ploscompbiol.org 8 July 2011 | Volume 7 | Issue 7 | e1002088
Figure 5. In Neurons Eps8 prevalently acts as a capper. a. Change in RFI and FII (i.e., Eps8:IRSp53:Fa and VASP:IRSp53:Fa normalized with
respect to their concentrations in wild type cells) in the various genetic backgrounds. Empty rectangles represent experimental results (see Table 3 in
Text S1), filled rectangles reproduce simulations of equations in Table 1 in Text S1 and parameters in Table 2 and Table 3 in Text S1. b. Complexes
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formed in HeLa cells by Abi1, Eps8, IRSp53, and VASP in the different genetic backgrounds plotted as percentage of total protein concentration in the
wild type. Simulations performed as in a. c. Removal of Eps8 from neurons significantly increases the amount of VASP bound to IRSp53. Cortex and
hippocampus lysates (1 mg) derived from Eps8 WT or KO mice were immunoprecipitated with anti-IRSp53 or anti Flag as control. Lysates (20 mg) and
immunoprecipitates (IPs) were immunoblotted with the indicated abs.
doi:10.1371/journal.pcbi.1002088.g005
Figure 6. Eps8:IRSp53 induces filopodia formation in VASP-deficient MVD7 cells after RNAi-mediated removal of CP. a. RNAi-
mediated downregulation of CP in MVD7 cells over-expressing IRSp53 increases filopodia formation. Control (WT scr) or CP (CP KD) RNAi-treated
MVD7 cells transfected with Flag–IRSp53 were fixed and stained with rhodamine–phalloidine or anti-flag to detect F-actin (red) or IRSp53 (blue),
respectively. Right panels, magnifications corresponding to the white dashed squares of the pictures on the left (the different channels are indicated).
DI are digitalized images obtained with Adobe Photoshop filters starting from the actin channel to highlight cells protrusions [12]. Bar is 10 mm (4 mm
for the magnifications). b. The expression of endogenous CP in cells interfered for CP (CP KD) or treated with scrambled oligo (WT scr) was analyzed
by immunoblotting with the indicated abs. CP reduction (85%) was determined using the software ImageJ, by analyzing the intensity of the signals
for CP in control cells (WT scr) or cells interfered for CP (CP KD), normalizing over vinculin signal. c. Change in RFI and FII (i.e., Eps8:IRSp53:Fa
normalized by its wild type value, see main text) in WT and CP knockout MVD7 cells. Empty rectangles represent experimental results, filled
rectangles simulations of equations in Table 1 in Text S1 and parameters in Table 2 and Table 3 in Text S1. d. Complexes formed in HeLa cells by Eps8,
IRSp53 and Abi1 in CP Kd and WT plotted as percentage of total protein concentration in the wild type. Simulations as in c.
doi:10.1371/journal.pcbi.1002088.g006
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since almost all VASP molecules are already present in VAS-
P:IRSp53:Fa complexes (Fig. 4B third panel). Consistently, upon
down-regulation of CP in HeLa cells via RNAi, we observed an
increase in the measured filopodia index similar to that predicted in-
silico (Fig. S3B). According to the model, CP removal does not
increase the amount of VASP:IRSp53:Fa, already maximal, but
increases both Eps8:Abi1:N and Eps8:IRSp53:Fa, this last having a
stronger effect than the previous on filopodia formation (Fig. S3C).
We finally asked how much of these results were dependent on
the precise choice of parameter values since, although most of them
are experimentally measured, other parameters are not (Table 2 in
Text S1). A sensitivity analysis showed that our results are largely
independent on parameter values in both cell types (Fig. S4).
Discussion
A number of proteins that regulate filopodia formation have
multiple biochemically-diverse functions. For examples, VASP
family proteins bundle filaments and protect barbed ends from
cappers, Formins nucleate new linear filaments and protect barbed
ends from capping, IRSp53 binds and bundles filaments and
deforms the PM. Coherently, all those different roles act in concert
to promote the formation of plasma membrane-linked, actin
filament and bundles required to induce and/or sustain filopodia
initiation or elongation. Eps8, instead, exerts actin-related bioche-
mical roles that produce opposite biological effects (capping of
filament ends that limits filament elongation, while crosslinking
that promotes filament bundling) on filopodia formation. Our
mathematical model shows that the dual function of Eps8 as a
capper or bundler as function of the different Eps8 complexes can
explain the seemingly paradoxical effects of Eps8 down-regulation
in filopodia formation in different cell types. Thus we propose that
Eps8 represents a molecular switch in the transduction of
signaling, either directing the cells towards a reduction or an
increase of filopodia, depending on the molecular context.
Model’s simplification
The model we propose is noticeably simple and yet it successfully
reproduces experimental data and even predicts the outcome of new
experiments. The biological system and experimental setting we
employed justified some of the simplifications of the model. For
example, since the phenotype we reproduce is a RFI that describes
the time-averaged ability of cells to form filopodia, an overly
detailed description of the physical process underlying filopodia
formation is not required. For this reason, we did not take intra-
cellular spatial localization into account and used values of total
protein concentrations considering a cell as a well-stirred system.
Other simplifications concern the molecular players of our
network. First, the model focuses only on a subset of well
characterized molecules that are involved in generating filopodia,
while it lacks some key components that have also recently been
implicated in filopodia formation, such as formin or Myosin
transporters, like Myosin X, or fascin. This choice was based on
recent experiments that have revealed that multiple and
independent mechanisms of filopodia formations may concomi-
tantly operate. Indeed, it was recently shown that in neurons
filopodia could be formed even after the ablation of all three VASP
family members upon expression of Myosin X or the activated
Formin, mDia2 [46]. This result was the basis to exclude the
above-mentioned molecular pathways from our model.
Secondly, we neglected some components even within the
pathway that we considered explicitly, as in the case of the cross
linker fascin, which was shown to be essential for filopodia
stabilization [8]. In this case, we hypothesize that diverse
crosslinking proteins or protein complexes may all be required
and act in a hierarchical and coordinated manner to promote
filopodia formation. Under this scenario, complexes formed
between filamentous actin, IRSp53 and its binding partners
Eps8 or VASP may serve as the ‘‘initiators’’ of filopodia by
promoting the ‘‘convergence and bundling’’ of actin filaments
close to the barbed ends oriented toward the PM mainly by virtue
of the established properties of IRSp53 to sense membrane
curvature and promote convex membrane deformation. Such a
mechanism for the initiation of membrane protrusions driven by
actin polymerization was proposed from theoretical analysis
[39,41]. The good agreement found in our study between the
experimental results and those obtained with our modeling
supports this mechanism for filopodia initiation, and suggests that
this hypothesis is worth further investigation.
Thirdly, we have not included all the known biological roles of
the proteins under consideration. In particular, recent work showed
that VASP may also act as an anti-capper and promote in a
processive manner filament elongation [4,6,7]. Notably, these latter
activities become significant mainly upon high-density clustering of
VASP. Although we have not explicitly introduced these additional
biochemical properties of VASP, they are partly intrinsic in our
model as they may occur in later critical steps of filopodia extension.
Our model, indeed, addresses what might be the very first step of
filopodia fomation that requires the deformation of the plasma
membrane and its coupling with the generation of actin filament
bundles to support extension. This event is possibly initiated by
proteins, such as IRSp53, and promoted, in a feedback loop fashion
(as proposed in [39,41]) by the bundling of pre-existing filaments.
Within this context IRSp53 and VASP may act synergically (as a
physically tethered complex) to cause filament bundling, and
increased barbed-end polymerization, thus increasing the local
protrusive force acting on the membrane. The membrane-
curvature sensing domain of IRSp53 completes the positive
feedback loop by causing IRSp53:VASP aggregation at the tips of
emergent membrane deformations. For the filopodia to grow
beyond this initiation stage, the actin filaments must remain
uncapped to elongate in a processive fashion and further stabilized
into tight bundles by actin cross-linkers, such as fascin.
VASP is likely essential also in this ‘‘second phase’’ by sliding
from the side to filament tips. Here, upon clusterization possibly
promoted by IRSp53-bound to the deformed plasma membrane,
VASP may elongate actin filaments while protecting them from
capping. According to this hypothesis, the initial recruitment of
VASP from IRSp53 has a dual role – both as a filament crosslinker,
bundling actin filaments into sufficiently stiff bundles, and recruiting
VASP in close proximity to sites of membrane deformation.
Finally, The RFI represents the fraction of cells that develop
filopodia, and thus the probability that cells with a certain genetic
background can develop filopodia. The formation of filopodia has
been proposed to be triggered by initiators of filopodia at the
plasma membrane, by a positive feedback loop [39,41]. Based on
this model, we find that the probability of forming filopodia is
linearly proportional to the average concentration of filopodia
initiation complexes (FII), the molecular species that contain both
F-actin and IRSp53. The model shows that the ‘‘probability of
forming filopodia’’ becomes significant only above a threshold
value of the filopodia initiator complexes, and it saturates as the
amounts of filopodia initiator complexes increase further (Fig. 3B).
Interestingly, our finding that real cells obey the above linear
relationship suggests that the physiological amounts of initiators in
the WT cells are kept close to the threshold value. In this regime,
small changes to the concentration of these initiators can both
easily induce a consistent increase or decrease of the probability of
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developing filopodia, thereby determining precisely the number of
filopodia forming cells in a population. This sort of behavior is in
agreement with previous observations [33] that indicate that cells
are naturally positioned close to the filopodia-formation threshold.
Eps8 is at the centre of a plastic network that controls
filopodia formation
Collectively, our systems analysis and experimental results
provide a cogent molecular and mathematical framework to
account for how the multifunctional activities of the components of
this network, with particular emphasis on Eps8 and VASP family
of proteins, are controlled in different cellular context. The
variable formation of distinct protein complexes either exerting
capping activities or promoting filament bundling is key in
determining the final biological output through quantitative
relationships that only a systems biology approach could reveal.
It is of note, for example, that the diverse combinatorial arrange-
ment of a limited numbers of components ensures a level of
unexpected plasticity of the network, so that seemingly opposite
actin-related activities (from capping to anticapping and filament
bundling) can be properly coordinated, ultimately differentially
controlling the promotion of filopodia. One implication of these
finding is that filopodia may not be considered entities governed
by different and entirely independent molecular pathways [46].
Rather, the formation of these structures is finely regulated by a
unique network connecting numerous molecular, presumably
interchangeable and functionally redundant, players through
distinct multi-protein complexes. In this context, our study shows
clearly the potential of differentially expressing components of the
network in terms of filopodia formation, as HeLa, MVD7
fibroblasts and neurons differ for the total concentration of 3
proteins of the network, and yet the effect in terms of filopodia is
dramatic. The experiments performed in VASP-family-deficient
MVD7 cells further show how the dynamic interplay of the
components of the network underlying filopodia formation makes
the system robust even to drastic changes, such as the absence of
apparently essential components. In conclusion, our results suggest
that the outer layer controlling filopodia formation plays a critical
role to make the machinery controlling filopodia formation at the
same time adaptable and capable of responding to different
extracellular stimuli and environmental conditions.
Materials and Methods
Expression vectors, antibodies, reagents and cells
Cytomegalovirus (CMV)-promoter-based and elongation factor-
1 (EF1) promoter-based eukaryotic expression vectors and GST
bacterial expression vectors were generated by recombinant PCR.
Myc–IRSp53 was a gift from S. Krugman (The Babraham Institu-
te, Babraham Research Campus, Cambridge, UK). All constructs
were sequence verified. The antibodies used were: monoclonal
anti-Eps8 (Transduction Laboratories, Lexington, KY); rabbit
polyclonal anti-GST, anti-Myc 9E10 (Babco, Berkeley, CA); anti-
Flag M2 (Sigma-Aldrich, St Louis, MO); rabbit polyclonal anti-
VASP (Immunoglobe, Himmelstald, Germany); monoclonal anti-
Abi-1 was previously described [48] and monoclonal anti-IRSp53
[12]. HeLa knocked down for CP or control cells were obtained by
transfecting cells with short hairpin loop oligos targeting human
CP gene (AACCTCAGCGATCTGATCGAC) or scramble oligos
(AACCTCAGCGATCTGATTGAC) respectively. For MVD7
cells, we used two Stealth RNAi oligos (Invitrogen) targeting
murine CP (T1=GAACCUCAGCGAUCUGAUCGACCUG;
T2=GAAGCACGCUGAAUGAGAUCUACUU) in combina-
tion with the appropriate scrambled oligo (scr T1s =GAACCU-
CAGUGAUCUGAUUGACCUG; scr T2s =AAGUAGAUUU-
CAUUAAGCGUGCUUC), as control.
Protein purification
His–Eps8 FL and His-IRSp53 were obtained as previously
described [12]. Recombinant VASP was expressed as GST fusion
protein in the BL21 Escherichia colistrain(Stratagene, Cedar
Creek, TX) and affinity purified using GS4B glutathione–
Sepharose beads (Amersham Pharmacia Biotech, Piscataway,
NJ). Eluted proteins were dialyzed in 50 mM Tris–HCl, 150 mM
NaCl, 1 mM DTT and 20% glycerol. GST–VASP was cleaved
from the GST using the PreScission protease (Amersham
Pharmacia Biotech, Piscataway, NJ) according to the manufac-
turer’s instructions. Actin was isolated from rabbit muscles and
purified in the Ca–ATP–G-actin form by Sephadex G-200
chromatography in G buffer (5 mM Tris–Hcl at pH 7.8,
0.1 mM CaCl2, 0.2 mM ATP, 1 mM DTT and 0.01% NaN3).
Fluorescence microscopy of actin bundling
Monomeric G-actin was polymerized as previously described
[12]. F-actin was mixed with varying concentrations of recombi-
nant and purified proteins (as described in the text) in F-buffer and
incubated at room temperature for 30 min. Actin was then labeled
with rhodamine–phalloidine and 0.1% DABCO and 0.1%
methylcellulose were added to the mixture. The samples were
mounted between a slide and a coverslip coated with poly-lysine
and imaged by fluorescence microscopy.
Transfection and immunofluorescence microscopy
HeLa cells, Cos7 cells and Hippocampal neurons were cultured
as described in [10], [12] and [16], respectively. VASP-family
deficient cells (MVD7) were a kind gift from F. Gertler and were
cultured as described [47]. HeLa, Cos7 and MVD7 cells seeded on
gelatin and were transfected with the indicated expression vectors
using FuGene (Invitrogen, Carlsbad, CA), according to the
manufacturer’s instructions. After 24 h, cells were processed for
epifluorescence or indirect immunofluorescence microscopy.
Briefly, cells were fixed in 4% paraformaldehyde for 10 min,
permeabilized in 0.1% Triton X-100 and 0.2% BSA for 10 min
and then incubated with the primary antibody for 45 min,
followed by incubation with the secondary antibody for 30 min. F-
actin was detected by staining with rhodamine–phalloidine at a
concentration of 6.7 U ml21.
CP knock down experiments
Hela: Epitope-tagged IRSp53 expressing or control cells seeded
on gelatine were transfected with CP or control oligos using
Oligofectamine (Invitrogen, Carlsbad, CA), according to the
manufacturer’s instructions.
MVD7: Epitope-tagged IRSp53 expressing or control cells
seeded on gelatine were subjected to a double transfection protocol
with CP or control oligos using Lipofectamine RNAiMAX
(Invitrogen, Carlsbad, CA), according to the manufacturer’s
instructions.
Generation of digitalized images
Images were obtained by applying the Adobe Photoshop filter
‘find edges’ to outline the cell contour. The average total length of
protrusions per cell extending from the cell somawas calculated using
ImageJ program in at least 30 different cells in triplicate experiments
and expressed as fold increase with respect to the average total length
of protrusions in control cells. Similarly, the number of branches per
cell was manually counted and expressed as above.
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Biochemical assays
Standard procedures in vitro binding, cell lysis and coimmuno-
precipitation were as previously described [12].
Mathematical simulations
We solved the equations at steady state using XPP-AUTO or
MATLAB.
For numerical analysis in MATLAB, we used the SBtoolbox2
[49]. To do this, we translated the set of equations in SBmodel
files.
The steady state of the system was found using the SBsteady-
state function, a function that numerically calculates the eigenva-
lues of the Jacobian matrix of the system.
Exploration of the parameter space in the model was carried out
either manually using the SBtoolbox2, or through optimization
algorithms found in the SBPD package [49].
Supporting Information
Figure S1 VASP synergizes with IRSp53 in bundling
actin filaments and in promoting filopodia formation. A.
VASP and Eps8 bundle actin filaments with low efficiency.
Fluorescence microscopy-based F-actin-bundling assay. F-actin
(1 mM) was incubated with 1 mM BSA as control or with
increasing concentrations of either Eps8 or VASP. Actin filaments
labeled with rhodamine–phalloidin were imaged using a fluores-
cence microscope as described in Materials and Methods and
[12]). Representative images of bundles filaments are shown. B.
The addition of IRSp53 increases the bundling efficiency of Eps8
and VASP. VASP is a much stronger bundler than Eps8 when in
complex with IRSp53. F-actin (1 mM) was incubated with 5 mM
IRSp53 alone or with the indicated concentrations of either Eps8
or VASP. F-Actin was visualized as described above. The
quantification of the bundling efficiency determined by measuring
the number of bundles/field is shown in Fig. 2A. C. The
concomitant expression of VASP and IRSp53 causes filopodia
formation in-vivo. Cos-7 cells transfected with Flag–IRSp53 or
GFP–VASP alone or in combination were fixed and processed for
epifluorescence microscopy to visualize GFP–VASP (green) and
stained with phalloidin or anti-Flag to detect F-actin (red) or
IRSp53 (blue), respectively. The concomitant expression of VASP
and IRSp53 increased membrane protrusions, which adopted the
shape of long and highly branched extensions (indicated by
arrows), where VASP and IRSp53 localized. The middle panels
represent threefold magnifications of the areas indicated in the top
panels. Filopodia induced by either IRSp53 alone or in
combination with VASP are indicated by arrowheads. Represen-
tative examples of the indicated transfected cells are shown also as
digitalized images to highlight the contour of cells (lower panels). A
protrusive index was determined by measuring the total length and
the number of branches of these protrusions as described in [12].
VASP and IRSp53 co-expressing cells displayed a 2-fold increase
in length and 3.1-fold increase in the number of branched
extension as compared with cells expressing only IRSp53 (not
shown). The scale bar represents 10 mm.
(TIF)
Figure S2 Protein expression in HeLa, neurons and
MVD7 cells. A. Similar expression levels of endogenous IRSp53,
Eps8 and CP were found in HeLa and Hippocampal Neuron-
s(Hip). B. We also determined the cytoplasmic concentration of
VASP and IRSp53 in HeLa. Total cellular lysates of an increasing
number of HeLa cells and increasing amounts of recombinant
human VASP (lower panels), or His-tagged IRSp53 (upper
panels), used as standards, were resolved by SDS-PAGE and
immunoblotted with the indicated abs. The following criteria were
used to estimate the concentrations of these proteins in neurons
reported in Table 2 in Text S1: i) we used previously estimated
average cell volumes for both HeLa and Neuronal cells
[12,42,44]); ii) in the case of VASP family members, the levels
of expression could not be estimated in neurons, where, however,
high levels of Evl and Mena have been previously determined
[45]. Absolute values for the concentration of Abi and Eps8 were
previously calculated in [12]. Notice how, due to overexpression,
in our simulations we use a higher value for the total concentration
of IRSp53 in HeLa cells (i.e., total IRSp53 is the sum of the
endogenous, reported here, and the overexpressed), Table 2 in
Text S1. C) The levels of Eps8, Abi1 and IRSp53 in MVD7 and
mouse embryo fibroblasts (MEFs) cells were measured as a fraction
of their level of expression in HeLa cells.
(TIF)
Figure S3 CP removal enhances IRSp53-mediated filo-
podia formation in HeLa cells. A. RNAi-mediated downreg-
ulation of CP in HeLa cells over-expressing IRSp53 increases
filopodia formation. Upper panels, control (WT scr) or CP (CP
KD) RNAi-treated HeLa cells transfected with Myc–IRSp53 were
fixed and stained with rhodamine–phalloidin or anti-myc to detect
F-actin (red) or IRSp53 (green), respectively. Bar is 10 mm. Middle
panels, images corresponding to the actin channel. Lower panels,
digitalized images obtained with Adobe Photoshop filters to
highlight cells protrusions [12]. The expression of Myc-IRSp53
and endogenous CP in interfered (CP KD) or control (WT scr)
cells was analyzed by immunoblotting with the indicated abs. A
reduction in CP levels after RNAi of about 85% was determined
using the software ImageJ, by analyzing the intensity of the signals
of protein bands corresponding to CP in control cells (WT scr) or
CP knocked down cells (CP KD) after normalizing for the total
amounts of proteins loaded in each lane with the vinculin signal. B.
Change in RFI and FII (i.e., Eps8:IRSp53:Fa and VAS-
P:IRSp53:Fa normalized by their wild type value, see main text)
in WT and CP knocked down HeLa cells. Empty rectangles
represent experimental results (see Table 3 in Text S1), filled
rectangles simulations of equations in Table 1 in Text S1 and
parameters in Table 2 and Table 3 in Text S1. C. Complexes
formed in HeLa cells by Abi1, Eps8, IRSp53, and VASP in
different genetic backgrounds plotted as percentage of total protein
concentrations in the wild type. Simulations as in B.
(TIF)
Figure S4 Sensitivity analysis. To verify the robustness of
the model described in the text, we measured the sensitivity
coefficients s, defined as s~
y(k){y(k)
y(k)
k
j
{kj
kj
where y is the observable
FII and j the parameter variation kj. k stands for a vector
containing all the parameters of the model, and k* stands for the
same vector with kj substituted by kj
*. For the three cellular types –
HeLa (A), Neurons (B) and MVD7 cells (C) – we have considered
the FII for the WT. We calculated the expression above using a
custom MATLAB scripts (available upon request) by increasing or
decreasing all the parameters in the model by plus or minus 1%
(green and blue bars in the Figure, respectively). A change in the
observable of over 1% indicates a sensitive parameter, while a
change below 1% suggests that the model is robust to changes in
that parameter. In the Figure, we plot s as a function of all
parameters in the wild type. Our simulations are largely
independent on parameter values in the three cell types, with
the exception of the ratio of the concentration of capping protein
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and the number of filament ends. Perturbing this ratio causes a
significant change in the polymerization of actin: by slightly
increasing the ratio of uncapped barbed ends, we observe a large
increase in the amount of actin polymerized at steady state in our
model. As discussed in the ‘‘Capping’’ section, this result is
consistent with the fact that cells are exquisitely sensitive to the
number of uncapped barbed ends.
(TIF)
Text S1 Contains equations and parameters used for the
simulations. Fig. S1 shows that both in vivo and in vitro VASP
synergizes with IRSp53 in bundling actin filaments and in promoting
filopodia formation. Fig. S2 reports the quantification of protein
Expression in HeLa, Neurons and MVD7 cells. Fig. S3 shows that
CP removal enhances IRSp53-mediated filopodia formation in
HeLa cells. Fig. S4 shows the results of stability analysis of the model.
(DOC)
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